BRUCE F JOHNSON
CIK 1212827 · last filed 2017-09-26
BRUCE F JOHNSON is a corporate insider who has filed 69 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for ITUS, was dated Sep 26, 2017. Across all open-market trades the lifetime net is +$198.5K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $26.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$26.30M
2
69
$198.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Anixa Biosciences Inc (ITUS) Delisted | Director | 604,817 | — | — | $198.5K | 30 | 2017-09-26 |
| CME | Director | 107,338 | $245.05 | $26.30M | $0 | 8 | 2014-08-27 |
Recent Filings
69 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-09-26 | Anixa Biosciences Inc (ITUS) Delisted | Grant (A) | +50,000 | $0 | EDGAR |
| 2016-07-05 | Anixa Biosciences Inc (ITUS) Delisted | Buy (P) | +4,500 | $14.7K | EDGAR |
| 2016-06-29 | Anixa Biosciences Inc (ITUS) Delisted | Buy (P) | +400 | $1.3K | EDGAR |
| 2016-06-20 | Anixa Biosciences Inc (ITUS) Delisted | Buy (P) | +400 | $1.4K | EDGAR |
| 2016-06-13 | Anixa Biosciences Inc (ITUS) Delisted | Buy (P) | +900 | $3.0K | EDGAR |
| 2016-06-10 | Anixa Biosciences Inc (ITUS) Delisted | Buy (P) | +500 | $1.8K | EDGAR |
| 2016-06-06 | Anixa Biosciences Inc (ITUS) Delisted | Buy (P) | +2,000 | $6.7K | EDGAR |
| 2016-06-01 | Anixa Biosciences Inc (ITUS) Delisted | Buy (P) | +2,604 | $8.6K | EDGAR |
| 2016-04-21 | Anixa Biosciences Inc (ITUS) Delisted | Buy (P) | +500 | $1.4K | EDGAR |
| 2016-04-11 | Anixa Biosciences Inc (ITUS) Delisted | Buy (P) | +200 | $564 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.